Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C J DuRand

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Drug Design and Discovery|April 1, 1996
Dopamine D2 receptor model explains binding affinity of neuroleptics: piquindone and its structure activity relationshipsM M Teeter, C J Durand
The Journal of Clinical Psychiatry|June 1, 1992
Psychiatrists and physical illness: clarificationC J DuRand, E J Knutsen
Journal of Medicinal Chemistry|September 2, 1994
Homology modeling of the dopamine D2 receptor and its testing by docking of agonists and tricyclic antagonistsM M Teeter, M Froimowitz, B Stec, et al.
The Journal of Clinical Psychiatry|September 1, 1992
Clozapine-induced myoclonic jerks and drop attacksI Berman, A Zalma, C J DuRand, et al.
The Journal of Clinical Psychiatry|September 1, 1994
Clozapine following ECT: a two-step treatmentA I Green, A Zalma, I Berman, et al.
Hospital & Community Psychiatry|January 1, 1992
Clozapine refusalC J DuRand, N J Jaretz, A Laddis, et al.
The American Journal of Psychiatry|July 1, 1995
A quarter century of suicide in a major urban jail: implications for community psychiatryC J DuRand, G J Burtka, E J Federman, et al.
Molecular Pharmacology|July 17, 2001
Modeling and mutational analysis of a putative sodium-binding pocket on the dopamine D2 receptorK A Neve, M G Cumbay, K R Thompson, et al.
Journal of Medicinal Chemistry|August 24, 2000
CoMFA-based prediction of agonist affinities at recombinant wild type versus serine to alanine point mutated D2 dopamine receptorsR E Wilcox, W H Huang, M Y Brusniak, et al.
Molecular Psychiatry|July 8, 1999
D4 dopamine receptor-mediated phospholipid methylation and its implications for mental illnesses such as schizophreniaA Sharma, M L Kramer, P F Wick, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Drug Design and Discovery|April 1, 1996
Dopamine D2 receptor model explains binding affinity of neuroleptics: piquindone and its structure activity relationshipsM M Teeter, C J Durand
The Journal of Clinical Psychiatry|June 1, 1992
Psychiatrists and physical illness: clarificationC J DuRand, E J Knutsen
Journal of Medicinal Chemistry|September 2, 1994
Homology modeling of the dopamine D2 receptor and its testing by docking of agonists and tricyclic antagonistsM M Teeter, M Froimowitz, B Stec, et al.
The Journal of Clinical Psychiatry|September 1, 1992
Clozapine-induced myoclonic jerks and drop attacksI Berman, A Zalma, C J DuRand, et al.
The Journal of Clinical Psychiatry|September 1, 1994
Clozapine following ECT: a two-step treatmentA I Green, A Zalma, I Berman, et al.
Hospital & Community Psychiatry|January 1, 1992
Clozapine refusalC J DuRand, N J Jaretz, A Laddis, et al.
The American Journal of Psychiatry|July 1, 1995
A quarter century of suicide in a major urban jail: implications for community psychiatryC J DuRand, G J Burtka, E J Federman, et al.
Molecular Pharmacology|July 17, 2001
Modeling and mutational analysis of a putative sodium-binding pocket on the dopamine D2 receptorK A Neve, M G Cumbay, K R Thompson, et al.
Journal of Medicinal Chemistry|August 24, 2000
CoMFA-based prediction of agonist affinities at recombinant wild type versus serine to alanine point mutated D2 dopamine receptorsR E Wilcox, W H Huang, M Y Brusniak, et al.
Molecular Psychiatry|July 8, 1999
D4 dopamine receptor-mediated phospholipid methylation and its implications for mental illnesses such as schizophreniaA Sharma, M L Kramer, P F Wick, et al.
Pageof 1